| Purity: | 99% min |
|---|---|
| Model Number: | CAS :401900-40-1 |
| Brand Name: | NJBN |
| Grade Standard: | |
| Type: | |
| Place of Origin: | China (Mainland) |
| MF: | C19H18F3N3O6 |
| Other Names: | S4 |
| CAS No.: | 401900-40-1 |
Quick Details
Specifications
High Purity Sarms Steroid Powder 401900-40-1 GTX-007 / S4 / Andarine
Quick Detail :
Payment Terms: Western union, money gram, T/T(Bank transfer),Bitcoin.
Delivery/Dispatch time : Within 24h upon the recipt of payment
Leading time : 4~6 working days once against of the payment
Description:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects.This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Quick Detail :
| Product Name | GTX-007 |
| Other name | Andarine, S4 |
| CAS | 401900-40-1 |
| Synonyms | S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide;N-[4-Nitro-3-(trifluoromethyl)phenyl]-(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methylpropanamide;Ostarine;(2R)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluorome |
| Class | Selective Androgen Receptor Modulators (SARM) |
| MF | C19H18F3N3O6 |
| MW | 441.36 |
| Purity | 99% min |
| Usage | Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy,[1] using the non-steroidal androgen antagonist bicalutamide as a lead compound. |
| Package | 10g/100g/500g/1000g foil bag or as you required |
Payment Terms: Western union, money gram, T/T(Bank transfer),Bitcoin.
Delivery/Dispatch time : Within 24h upon the recipt of payment
Leading time : 4~6 working days once against of the payment
Description:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects.This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
SARMs:
MK-2866 CAS:1202044-20-9, 841205-47-8
LGD-4033 CAS:1165910-22-4
GW-501516 CAS:317318-70-0
MK-677 CAS:159752-10-0
GTX-007/S4/Andarine CAS:401900-40-1
SR-9009 CAS:1379686-30-2
RAD-140 CAS:118237-47-0
YK-11 CAS:431579-34-9
AICAR CAS:2627-69-2
GW0742 CAS:317318-84-6
GS5816 CAS:1377049-84-7
